Direct-Marking UDI Draft Lays Out Tips, Timelines For Reprocessed Devices
This article was originally published in The Gray Sheet
The agency issued draft guidance document on direct marking requirements for unique device identifiers, seeking guidance on the definition of "reprocessing" and laying out timelines.
You may also be interested in...
US FDA's device center has made some clarifications to the way it would like to see sponsors directly mark medical devices intended to be reprocessed and reused, and it has beefed up its preferred approach to Unique Device Identification labeling in a final guidance on direct UDI marking released Nov. 16.
The long-awaited unique device identifier final rule is intended to help FDA, device companies and health care providers track medical devices. The rule addresses many of industry’s concerns with FDA’s initial proposal and was met with general support by companies.
Pharma manufacturing is operating well below normal levels in India, disrupted by labor absenteeism and supply chain issues amid the ongoing lock-down in the country, though the government is actively engaged in addressing bottlenecks. A speedy recovery is vital not just for domestic supplies.